Aashka Hospitals Ltd vs Vanta Bioscience Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Aashka Hospitals Ltd is ₹ 92.6 as of 23 Oct 15:30 . The P/E Ratio of Aashka Hospitals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Vanta Bioscience Ltd changed from 229.6 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Aashka Hospitals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Vanta Bioscience Ltd changed from ₹ 102.89 crore on March 2021 to ₹ 13.96 crore on March 2025 . This represents a CAGR of -32.93% over 5 years The Dividend Payout of Aashka Hospitals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Vanta Bioscience Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Aashka Hospitals Ltd

Aashka Hospitals Limited was originally incorporated as Private Limited Company in the name of 'Aashka Hospitals Private Limited' vide Certificate of Incorporation dated November 09, 2012 issued by the Registrar of Companies, Gujarat, Dadra and Nagar Havelli.
Subsequently, Company got converted into a Public Limited Company and the name of the Company was changed to 'Aashka Hospitals Limited' vide a fresh Certificate of Incorporation dated July 23, 2018 issued by the Registrar of Companies, Ahmedabad. Aashka Hospitals is a Multi - Speciality hospital founded in year 2012, in Gujarat i.e.
Gandhinagar.
It provides health care services and serves patients in India.
The Company is an integrated healthcare service provider, committed to deliver quality healthcare services to patients in modern facilities that includes prevention, best treatment and proper rehabilitation.

About Vanta Bioscience Ltd

Vanta Bioscience Limited (VBS) was originally incorporated as a Private Limited Company on 29th April 2016 and was converted into a Public Limited Company with effect from 17th March 2017. VBS is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.
In addition, Company provide risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product.
It also provides expert services for determination of health based exposure limits (e.

FAQs for the comparison of Aashka Hospitals Ltd and Vanta Bioscience Ltd

Which company has a larger market capitalization, Aashka Hospitals Ltd or Vanta Bioscience Ltd?

Market cap of Aashka Hospitals Ltd is 216 Cr while Market cap of Vanta Bioscience Ltd is 14 Cr

What are the key factors driving the stock performance of Aashka Hospitals Ltd and Vanta Bioscience Ltd?

The stock performance of Aashka Hospitals Ltd and Vanta Bioscience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aashka Hospitals Ltd and Vanta Bioscience Ltd?

As of October 25, 2026, the Aashka Hospitals Ltd stock price is INR ₹92.6. On the other hand, Vanta Bioscience Ltd stock price is INR ₹20.4.

How do dividend payouts of Aashka Hospitals Ltd and Vanta Bioscience Ltd compare?

To compare the dividend payouts of Aashka Hospitals Ltd and Vanta Bioscience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.